Researchers find new clue to clinical trial failures of MMP cancer therapies
Hidetoshi Mori and Mina Bissell. Credit: Roy Kaltschmidt
Proposed cancer therapeutic drugs based on blocking the catalytic activities of matrix metalloproteinases (MMPs), which profoundly remodel the environment surrounding a breast cell, have performed poorly in clinical trials. In mouse studies of MMP14, an enzyme that is often highly expressed in breast cancer, Berkeley Lab researchers have found a possible clue as to why. If confirmed for other MMPs, the finding could point the way to new strategies for future MMP-based cancer therapies.
Berkeley Lab Distinguished Scientist Mina Bissell led a study of MMP14 in nulliparous mice that shows it does not promote invasive behavior in the mammary gland through its catalytic domain, as has been almost universally believed by the cancer research community. Instead, MMP14 promotes invasion through its transmembrane domain, specifically through the direct association of that domain with the beta 1 subunit of integrin (Itgb1), a signaling molecule involved in mammary gland branching and invasion into the fat pad. The Bissell lab previously showed that mis-regulation of Itgb1 plays a role in breast cancer.
"The reason anti-MMP drugs failed in clinical trials may be that they were aimed at the catalytic domain of these enzymes, which we all thought was the culprit," Bissell says. "The assumption has been that all MMP functions are in the catalytic domain, but we found that MMP14 promotes cancer through its transmembrane domain by mediating signals from the extracellular matrix (ECM) via cross talk and association with Itgb1."
Since high expression of MMP14 has been strongly linked to poor outcomes, including increased death, for breast cancer patients, this membrane-bound enzyme became a prime target for pharmaceutical companies seeking to develop breast cancer therapies. The idea was to inhibit not only MMP14, but also any of the other MMPs from functioning.
"The failure and indeed resulting damage of all anti-MMP drugs in clinical trials indicated that MMPs as a class have useful functions that were also being blocked, leading to bad consequences for patients" Bissell says.
The essential non-proteolytic MMP14 activity that Hidetoshi Mori, a scientist in Bissell's research group lab, and other collaborators identified was the association between the transmembrane/cytoplasmic domain of MMP14 and Itgb1 molecules. The MMP14 was found to be expressed in the mammary epithelial cells of nulliparous mice at the tips of mammary gland branches, where it binds with Itgb1 to control the intracellular and extracellular signals that enable the cells to navigate and invade the fatty stroma.
"Invasion of the stroma and branching by mammary epithelial cells are required for normal breast development. Silencing the MMP14 prevents epithelial cells from moving into the stroma and reduces Itgb1 levels, which results in less branching," Mori says.
Adds Bissell, "When MMP14 interacts with Itgb1 in a tumor, however, these same processes are subverted, the tumor is able to hijack normal cell pathways and cancer is promoted."
These findings suggest that the non-catalytic activity in MMPs could provide a new target for future clinical strategies.
Provided by Lawrence Berkeley National Laboratory
- Researchers Isolate Protein Domain Linked to Tumor Progression Feb 17, 2009 | not rated yet | 0
- New class of proteins allows breast cancer cells to evade tyrosine kinase inhibitors Aug 13, 2012 | not rated yet | 0
- Researchers illuminate laminin's role in cancer formation Mar 07, 2011 | not rated yet | 0
- Researchers identify possible new oncogene and future therapy target Sep 11, 2012 | not rated yet | 0
- Scientists find that normal breast cells help kill cancer cells Apr 13, 2011 | not rated yet | 0
- Motion perception revisited: High Phi effect challenges established motion perception assumptions Apr 23, 2013 | 3 / 5 (2) | 2
- Anything you can do I can do better: Neuromolecular foundations of the superiority illusion (Update) Apr 02, 2013 | 4.5 / 5 (11) | 5
- The visual system as economist: Neural resource allocation in visual adaptation Mar 30, 2013 | 5 / 5 (2) | 9
- Separate lives: Neuronal and organismal lifespans decoupled Mar 27, 2013 | 4.9 / 5 (8) | 0
- Sizing things up: The evolutionary neurobiology of scale invariance Feb 28, 2013 | 4.8 / 5 (10) | 14
Pressure-volume curve: Elastic Recoil Pressure don't make sense
May 18, 2013 From pressure-volume curve of the lung and chest wall (attached photo), I don't understand why would the elastic recoil pressure of the lung is...
If you became brain-dead, would you want them to pull the plug?
May 17, 2013 I'd want the rest of me to stay alive. Sure it's a lousy way to live but it beats being all-the-way dead. Maybe if I make it 20 years they'll...
MRI bill question
May 15, 2013 Dear PFers, The hospital gave us a $12k bill for one MRI (head with contrast). The people I talked to at the hospital tell me that they do not...
Ratio of Hydrogen of Oxygen in Dessicated Animal Protein
May 13, 2013 As an experiment, for the past few months I've been consuming at least one portion of Jell-O or unflavored Knox gelatin per day. I'm 64, in very...
Alcohol and acetaminophen
May 13, 2013 Edit: sorry for the typo in the title , can't edit I looked around on google quite a bit and it's very hard to find precise information on the...
Marie Curie's leukemia
May 13, 2013 Does anyone know what might be the cause of Marie Curie's cancer
- More from Physics Forums - Medical Sciences
More news stories
The use of a smartphone application significantly improves patients' preparation for a colonoscopy, according to new research presented today at Digestive Disease Week (DDW). The preparation process, which begins days in ...
Cancer 4 hours ago | not rated yet | 0
Research presented at Digestive Disease Week (DDW) explores new methods for managing digestive health through diet and lifestyle.
Cancer 4 hours ago | not rated yet | 0
A ground-breaking advance in colonoscopy technology signals the future of colorectal care, according to research presented today at Digestive Disease Week(DDW). Additional research focuses on optimizing the minimal withdrawal ...
Cancer 19 hours ago | 5 / 5 (2) | 0
(HealthDay)—Concurrent use of two immune checkpoint antibodies—ipilimumab and nivolumab—may be effective for the treatment of advanced melanoma, according to a proof-of-principal study presented in ...
Cancer May 17, 2013 | not rated yet | 0
(HealthDay)—The risks of metastasis and death associated with cutaneous squamous cell carcinoma (CSCC) are low, but significant, and risk factors for poor outcome include tumor diameter, invasion beyond ...
Cancer May 17, 2013 | not rated yet | 0 |
Regular consumption of coffee is associated with a reduced risk of primary sclerosing cholangitis (PSC), an autoimmune liver disease, Mayo Clinic research shows. The findings were being presented at the Digestive Disease ...
5 hours ago | not rated yet | 0 |
Patients with treatment-resistant major depression saw dramatic improvement in their illness after treatment with ketamine, an anesthetic, according to the largest ketamine clinical trial to-date led by researchers from the ...
5 hours ago | 4.5 / 5 (2) | 0 |
There are significant cost and risk factors associated with two procedures commonly used to diagnose or treat gastrointestinal problems, according to research presented at Digestive Disease Week (DDW).
4 hours ago | not rated yet | 0
An increasing number of U.S. children are experiencing gastrointestinal issues that require interventions to resolve, according to research presented at Digestive Disease Week (DDW).
19 hours ago | not rated yet | 0 |
The latest makeover to a massive psychiatric tome honored by some, reviled by others and even called the "Bible" of mental disorders is being released Saturday with a host of new changes.
17 hours ago | not rated yet | 0
A new case of the deadly coronavirus has been detected in Saudi Arabia where 15 people have already died after contracting it, the health ministry announced on Saturday on its Internet website.
17 hours ago | not rated yet | 0